Clinical Trial Update: A Study to Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating icotinib alone vs icotinib with radiation therapy for brain metastases in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• icotinib (icotinib)

Snippet

Sponsor: Betta Pharmaceuticals Co., Ltd. | Conditions: Non Small Cell Lung Cancer, Brain Metastases | Phase 3 | Status: UNKNOWN